Incompletely processed N‐glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS)

Congenital dyserythropoietic anaemia type II, or HEMPAS (hereditary erythroblastic multinuclearity with positive acidifed serum lysis test) is a genetic disease caused by membrane disorganization of erythroid cells. The primary defect of this disease lies in the gene encoding enzyme(s) which is responsible for the biosnythesis of Asn‐linked oligosacharides chains of glycoproteins (Fukuda et al. 1990). In order to know whether this gene defect affects the glycosylation in the cells other than the erythroid cells, the carbohydrate structures of the transferrin isolated from the sera of HEMPAS patients were analysed. Fast atom bombardment mass spectrometry analysis showed the presence of high mannose type and hybrid type oligosaccharides in the HEMPAS transferrin which is in contrast to the complex‐type oligosac charides found in the normal transferrin. The results strongly suggest that biosynthesis of Asn‐linked oligosaccharide chains in HEMPAS hepatocytes is disturbed. As a result, the serum glycoproteins with incompletely processed carbohydrates are circulating in the plasma in HEMPAS patients. but they must have been absorbed by the cells in the liver and the reticuloendothelial cells. Upon intravenous infusion into rats, as much as 30% of the HEMPAS transferrin was cleared from the plasma circulation. The majority of the HEMPAS transferrins was taken up by the liver, and transferrin was distributed both in the hepatocytes and the Kupffer cells. The presence of enormous amounts of aberrantly glycosylated serum glycoproteins may lead to the liver cirrhosis and secondary tissue siderosis seen in HEMPAS patients.

[1]  H Stibler,et al.  Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. , 1991, Clinical chemistry.

[2]  A. Dell,et al.  Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Maley,et al.  Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. , 1989, Analytical biochemistry.

[4]  P. Scartezzini,et al.  Congenital dyserythropoietic anaemia type II (HEMPAS): characterization of aberrant intracellular organelles by immunogold electron microscopy , 1987, British journal of haematology.

[5]  H. Heimpel,et al.  Glycolipids and glycopeptides of red cell membranes in congenital dyserythropoietic anaemia type II (CDA II) , 1987, British journal of haematology.

[6]  A. Dell,et al.  Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II. , 1987, The Journal of biological chemistry.

[7]  A. Dell,et al.  A rapid mass-spectrometric procedure for probing the non-reducing structures of lactosaminoglycan-containing glycoconjugates. , 1985, Carbohydrate research.

[8]  J. Vliegenthart,et al.  Primary structure of two sialylated triantennary glycans from human serotransferrin , 1985, FEBS letters.

[9]  U. Testa,et al.  Defect in glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia type II (HEMPAS) , 1984, British journal of haematology.

[10]  M. Tanner,et al.  Incomplete glycosylation of erythrocyte membrane proteins in congenital dyserythropoietic anaemia Type II (CDA II) , 1983, British journal of haematology.

[11]  P. Gleeson,et al.  Control of branching during the biosynthesis of asparagine-linked oligosaccharides. , 1983, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

[12]  M. Cazzola,et al.  Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias , 1983, British journal of haematology.

[13]  G. Margueritte,et al.  Alterations of Globin Chain Synthesis and of Red Cell Membrane Proteins in Congenital Dyserythropoietic Anemia I and II , 1982, Pediatric Research.

[14]  P. Scartezzini,et al.  Decreased glycosylation of band 3 and band 4‐5 glycoproteins of erythrocyte membrane in congenital dyserythropoietic anaemia type II , 1982, British journal of haematology.

[15]  T. Gabuzda,et al.  Normal serum ferritin levels in a patient with HEMPAS syndrome and iron overload. , 1982, American journal of clinical pathology.

[16]  J. Banga,et al.  Red cell membrane protein anomalies in congenital dyserythropoietic anaemia, type II (HEMPAS) , 1982 .

[17]  R. Lowenthal,et al.  Erythrocyte membrane proteins in an unusual case of congenital dyserythropoietic anaemia type II (CDA II) , 1982, British journal of haematology.

[18]  S. Heinemann,et al.  The ultrastructural differentiation of the clonal myogenic cell line L6 in normal and high K+ medium. , 1977, Developmental biology.

[19]  H. Heimpel,et al.  Congenital Dyserythropoietic Anaemia, Types I and II: Aberrant Pattern of Erythrocyte Membrane Proteins in CDA II, as Revealed by Two‐dimensional Polyacrylamide Gel Electrophoresis , 1977, British journal of haematology.

[20]  F. W. Sweat,et al.  Stimulation of adenylate cyclase from isolated hepatocytes and Kupffer cells. , 1975, The Journal of biological chemistry.

[21]  A. Morell,et al.  Mammalian Hepatic Lectin , 1974, Science.

[22]  P. Seglen Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. , 1973, Experimental cell research.

[23]  S. Lewis,et al.  Hempas: congenital dyserythropoietic anaemia (type II). , 1973, The Quarterly journal of medicine.

[24]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[25]  S. Lewis,et al.  Hereditary Erythroblastic Multinuclearity Associated with a Positive Acidified‐Serum Test: a Type of Congenital Dyserythropoietic Anaemia , 1969, British journal of haematology.

[26]  H. Heimpel,et al.  Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. , 1968, Helvetica medica acta.

[27]  F. Putnam,et al.  Purification and properties of human transferrin C and a slow moving genetic variant. , 1967, The Journal of biological chemistry.

[28]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[29]  M. Fukuda,et al.  Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. , 1989, Blood.

[30]  A. Dell,et al.  F.A.B.-mass spectrometry of carbohydrates. , 1987, Advances in carbohydrate chemistry and biochemistry.

[31]  P. Jacobs,et al.  Congenital dyserythropoietic anaemia (type II) presenting with haemosiderosis. , 1987, Acta haematologica.

[32]  Y. Levo,et al.  Severe hemochromatosis: the predominant clinical manifestation of congenital dyserythropoietic anemia type 2. , 1985, Acta haematologica.

[33]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.

[34]  G. Strecker,et al.  Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin , 1975, FEBS letters.

[35]  H. Marti [The erythrocyte membrane]. , 1968, Schweizerische medizinische Wochenschrift.